Markets
Yiwen Lu

US stocks edge higher as Nvidia earnings await


The S&P 500 was up 0.2% on Tuesday. The Nasdaq 100 rose 0.3%, while the Russell 2000 dropped 0.7%. Investors were hesitant to move aggressively on Tuesday; the S&P 500’s daily range was less than 38 points, one of its narrowest trading bands of the month.

The sector performance was also mixed. Technology and financials were the leading S&P 500 sector ETFs, with a 0.6% and 0.5% gain, respectively. On the other hand, energy lagged the most and dropped 0.9%.

Wall Street is expected to be fully attentive to Nvidia’s earnings after the bell on Wednesday. Shares of the company closed up 1.5%, recouping some losses from Monday. Among other chip stocks, Super Micro Computer lost 2.6% after Hindenburg Research announced a bet against the stock. In early trading, the prices dropped as much as 8.7%. 

Walgreens was the worst S&P 500 performer, down as much as 8.8% after Eli Lilly lowered prices for its weight loss drug Zepbound, which it sells direct-to-consumer. Shares of Paramount also fell 7.2%, after Edgar Bronfman Jr. dropped his bid to buy the company.

Oil prices were lower, as the benchmark West Texas Intermediate slid 2.2%, putting a pause on a three-day rally.

More Markets

See all Markets
markets

Stocks get a jolt as Netanyahu says Israel is helping US efforts to open Strait of Hormuz

Israeli Prime Minister Benjamin Netanyahu said his country was helping with US efforts to open the Strait of Hormuz, putting a jolt into stocks. 

The S&P 500, which had been solidly negative for most of the day, turned slightly green after the remarks. The rebound lost a bit of steam shortly thereafter, but stocks still remained higher than they were before Netanyahu’s comments.

“Israel is helping, in its own way, in intel and other means, the American efforts to open the Strait of [Hormuz],” Netanyahu said, according to a video of the press conference.

“Israel is helping, in its own way, in intel and other means, the American efforts to open the Strait of [Hormuz],” Netanyahu said, according to a video of the press conference.

markets

Gold tumbles as market sees Fed shifting toward inflation fighting

Gold and gold miners tumbled Thursday, as the rolling Iran war energy crisis revived worries about inflation and pushed the market to take additional rate cuts this year off the table.

Gold (SPDR Gold Shares ETF) futures dropped roughly 6% shortly after 12 pm ET, hammering share prices for miners Newmont and Freeport-McMoRan. Silver (iShares Silver Trust) futures were down nearly 9%

The decline in precious metals came alongside another sharp rise in energy prices. US benchmark crude oil (United States Oil Fund LP) and natural gas prices both jumped more than 3%, after major Iranian attacks on Qatari energy infrastructure. US retail gasoline prices tracked by AAA hit $3.884, up 33% from the end of last month, when a joint US-Israeli attack on Iran ignited hostilities.

Normally, gold prices are seen as a hedge on inflation, which might suggest that they should rise alongside expectations for persistent price increases.

But the speed of the Iran war energy shock — which will add to inflationary pressures already visible in recent economic reports such as this week’s Producer Price Index and could become a political problem for the Trump administration — has nudged traders to change their their views on whether the Federal Reserve would be able to deliver rate cuts widely expected just a few weeks ago.

Yields on shorter-maturity US Treasury notes shot higher Thursday — reflecting expectations for tighter monetary policy. And prices in the market for Fed Funds futures suggest traders no longer see the US central bank cutting interest rates this year at all. (Early this month, market pricing implied expectations for two more cuts this year.)

On Thursday yields fell on longer-term US government securities, such as the US 30-year bond. That suggests the market thinks a Fed shift toward inflation-fighting and away from rate-cutting would likely result in some decline in growth and, or inflation, helping to explain the drop in precious metals prices, as there would be less of a need for inflation hedges in such a scenario.

The decline in precious metals came alongside another sharp rise in energy prices. US benchmark crude oil (United States Oil Fund LP) and natural gas prices both jumped more than 3%, after major Iranian attacks on Qatari energy infrastructure. US retail gasoline prices tracked by AAA hit $3.884, up 33% from the end of last month, when a joint US-Israeli attack on Iran ignited hostilities.

Normally, gold prices are seen as a hedge on inflation, which might suggest that they should rise alongside expectations for persistent price increases.

But the speed of the Iran war energy shock — which will add to inflationary pressures already visible in recent economic reports such as this week’s Producer Price Index and could become a political problem for the Trump administration — has nudged traders to change their their views on whether the Federal Reserve would be able to deliver rate cuts widely expected just a few weeks ago.

Yields on shorter-maturity US Treasury notes shot higher Thursday — reflecting expectations for tighter monetary policy. And prices in the market for Fed Funds futures suggest traders no longer see the US central bank cutting interest rates this year at all. (Early this month, market pricing implied expectations for two more cuts this year.)

On Thursday yields fell on longer-term US government securities, such as the US 30-year bond. That suggests the market thinks a Fed shift toward inflation-fighting and away from rate-cutting would likely result in some decline in growth and, or inflation, helping to explain the drop in precious metals prices, as there would be less of a need for inflation hedges in such a scenario.

markets

Novo says FDA has approved high-dose Wegovy shot

The Food and Drug Administration approved Novo Nordisk’s high-dose Wegovy shot, the company announced on Thursday.

Wegovy HD, a once-weekly 7.2-milligram injection, helped patients lose 20.7% of their body weight after 72 weeks, putting it in line with Eli Lilly’s competitor drug, Zepbound. By comparison, Wegovy typically has a maximum dose of 2.4 milligrams, which resulted in 15% weight reduction over 68 weeks in trials.

Wegovy HD was the first drug to be approved through the FDA’s new priority voucher system. This comes as Novo, despite being early to the GLP-1 boom, has been outpaced in sales by Lilly. The company released a pill version of Wegovy in January, which has shown strong early uptake, though new competitor products are set to debut this year and next.

The stock is down about 1.6% for the day, but was down nearly 3% before the announcement.

markets

Intuit, Workday jump amid Iran war fueling flight-to-software trade

Cash flow positive software companies — the same ones that were seen as doomed to obsolescence by AI a few weeks back — jumped Thursday, with Oracle, Workday, Intuit, and Salesforce staying above water despite the general downtrend in the big indexes.

Some of the uptick is likely linked to the better-than-expected weekly jobless claims numbers that came in early today, which eased concerns about a recession brought on by the most recent monthly employment report. (Payroll-processing stocks like Paycom Software, Paychex, and Automatic Data Processing are clearly breathing a sign of relief.)

And given that these software companies often have a “seat-based” revenue model, the fact that human butts are not rapidly being replaced by AI-enhanced robot keisters gives them a lift as well.

Also as we’ve said before, amid the chaos and uncertainty of the Iran war, the steady cash flows and predictable short-term outlook of software-as-a-service stocks have a definite appeal.

Even if you think that over the long term AI will end up slaughtering these cash cows, that’s a problem for a day perhaps three to five years in the future, whereas the Iran war is a growing risk investors increasingly can’t ignore today.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.